As I mentioned, there are a lot of studies of these drugs, but very few where they are tested head-to-head
Gynecological Endocrinology, 38(2), 110115
It is NOT intended for human or veterinary use, injection, consumption, diagnostics, or therapeutic applications
GLP-1 receptor agonists also help people with type 2 diabetes lose weight and lower their risk of major cardiovascular events in individuals with established cardiovascular disease
BPC-157 remains investigational by comparison, with animal data suggesting potential but no controlled human trials confirming cardiovascular benefits
The repair signature is reminiscent of the copper signature very recently demonstrated in regulatory T cells, whose energetic and functional phenotype is highly dependent on free intracellular copper